Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Apr;11(4):683–687. doi: 10.1128/aac.11.4.683

Indirect Mouse Model for the Evaluation of Potential Antiviral Compounds: Results with Venezuelan Equine Encephalomyelitis Virus

Ralph W Kuehne 1, Wallace L Pannier 1, Edward L Stephen 1
PMCID: PMC352050  PMID: 856020

Abstract

An indirect mouse model was utilized to evaluate the antiviral activity of several compounds against Venezuelan equine encephalomyelitis (VEE) virus infection in mice. Mice were given various dosages of lysine-stabilized polyriboinosinic acid-polyribocytidylic acid, a tilorone analogue, kethoxal, or mepacrine before and/or shortly after receiving one of several dose levels of attenuated strain TC-83 VEE virus. Twenty-one days later, the same mice were rechallenged intracranially with virulent Trinidad donkey strain VEE virus. Susceptibility to rechallenge was interpreted as evidence of drug effectiveness in completely preventing the initial immunizing virus infection. In contrast, if a drug lacked antiviral effectiveness, the initial attenuated infection stimulated sufficient immunity to protect mice against the virulent rechallenge. Both of the interferon inducers, lysine-stabilized polyriboinosinic acid-polyribocytidylic acid and tilorone analogue 11,567, possessed significant (P < 0.01) antiviral activity based upon this indirect model, whereas mepacrine and kethoxal were inactive. Results using the indirect method were confirmed by using the conventional direct method for evaluating the effectiveness of potentially useful antiviral compounds. The indirect mouse model described should prove useful for studying drug efficacy against certain viruses that are lethal only by intracranial inoculation.

Full text

PDF
683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchnall R. A. The continuing search for antiviral drugs. Adv Pharmacol Chemother. 1973;11:295–318. [PubMed] [Google Scholar]
  2. Buthala D. A. Experience gained in screening for synthetic antiviral compounds. Ann N Y Acad Sci. 1965 Jul 30;130(1):17–23. doi: 10.1111/j.1749-6632.1965.tb12534.x. [DOI] [PubMed] [Google Scholar]
  3. Davies W. L., Grunert R. R., Hoffmann C. E. Influenza virus growth and antibody response in amantadine-treated mice. J Immunol. 1965 Dec;95(6):1090–1094. [PubMed] [Google Scholar]
  4. De Clercq E., Merigan T. C. Bis-DEAE-fluorenone: mechanism of antiviral protection and stimulation of interferon production in the mouse. J Infect Dis. 1971 Feb;123(2):190–199. doi: 10.1093/infdis/123.2.190. [DOI] [PubMed] [Google Scholar]
  5. Desmyter J., Melnick J. L., Rawls W. E. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol. 1968 Oct;2(10):955–961. doi: 10.1128/jvi.2.10.955-961.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dice J. R., Rightsel W. A., Schabel F. M., Jr, McLean I. W., Jr Experiences in developing potential antiviral compounds. Ann N Y Acad Sci. 1965 Jul 30;130(1):24–30. doi: 10.1111/j.1749-6632.1965.tb12535.x. [DOI] [PubMed] [Google Scholar]
  7. GOULET N. R., COCHRAN K. W., BROWN G. C. Differential and specific inhibition of ECHO viruses by plant extracts. Proc Soc Exp Biol Med. 1960 Jan;103:96–100. doi: 10.3181/00379727-103-25424. [DOI] [PubMed] [Google Scholar]
  8. HURST E. W., PETERS J. M., MELVIN P. The action of mepacrine and trypan red in a number of virus diseases. Br J Pharmacol Chemother. 1952 Sep;7(3):473–481. doi: 10.1111/j.1476-5381.1952.tb00714.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jordan G. W. Interferon sensitivity of Venezuelan equine encephalomyelitis virus. Infect Immun. 1973 Jun;7(6):911–917. doi: 10.1128/iai.7.6.911-917.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaufman H. E., Centifanto Y. M., Ellison E. D., Brown D. C. Tilorone hydrochloride: human toxicity and interferon stimulation. Proc Soc Exp Biol Med. 1971 May;137(1):357–360. doi: 10.3181/00379727-137-35576. [DOI] [PubMed] [Google Scholar]
  11. Kuehne R. W., Pannier W. L., Stephen E. L. Evaluation of various analogues of tilorone hydrochloride against Venezuelan equine encephalitis virus in mice. Antimicrob Agents Chemother. 1977 Jan;11(1):92–97. doi: 10.1128/aac.11.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Levy H. B., Baer G., Baron S., Buckler C. E., Gibbs C. J., Iadarola M. J., London W. T., Rice J. A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis. 1975 Oct;132(4):434–439. doi: 10.1093/infdis/132.4.434. [DOI] [PubMed] [Google Scholar]
  13. Maugh T. H., 2nd Chemotherapy: antiviral agents come of age. Science. 1976 Apr 9;192(4235):128–132. doi: 10.1126/science.192.4235.128. [DOI] [PubMed] [Google Scholar]
  14. Mayer G. D., Krueger R. F. Tilorone hydrochloride: mode of action. Science. 1970 Sep 18;169(3951):1214–1215. doi: 10.1126/science.169.3951.1214. [DOI] [PubMed] [Google Scholar]
  15. Randall R., Mills J. W. FATAL ENCEPHALITIS IN MAN DUE TO THE VENEZUELAN VIRUS OF EQUINE ENCEPHALOMYELITIS IN TRINIDAD. Science. 1944 Mar 17;99(2568):225–226. doi: 10.1126/science.99.2568.225. [DOI] [PubMed] [Google Scholar]
  16. SCHABEL F. M., Jr VIRUS CHEMOTHERAPY - WHY AND HOW. Ala J Med Sci. 1965 Apr;2:149–154. [PubMed] [Google Scholar]
  17. Schafer T. W., Lockart R. Z., Jr Interferon required for viral resistance induced by poly I.poly C. Nature. 1970 May 2;226(5244):449–450. doi: 10.1038/226449a0. [DOI] [PubMed] [Google Scholar]
  18. Sidwell R. W., Dixon G. J., Sellers S. M., Schabel F. M., Jr In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. Appl Microbiol. 1968 Feb;16(2):370–392. doi: 10.1128/am.16.2.370-392.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Spertzel R. O., Hilmas D. E., Brown J. R., Mason D. W. Response of irradiated mice to live-virus (TC-83) immunization. Infect Immun. 1975 Mar;11(3):481–487. doi: 10.1128/iai.11.3.481-487.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Spertzel R. O., Kahn D. E. Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in Equidae. J Am Vet Med Assoc. 1971 Sep 15;159(6):731–738. [PubMed] [Google Scholar]
  21. Tazulakhova E. B., Novokhatsky A. S., Yershov F. I. Interferon induction by, and antiviral effect of poly (rI)--poly (rC) in experimental viral infection. Acta Virol. 1973 Nov;17(6):487–492. [PubMed] [Google Scholar]
  22. UNDERWOOD G. E., WEED S. D. The effect of carbonyl compounds on poliovirus. Virology. 1961 Jan;13:138–139. doi: 10.1016/0042-6822(61)90041-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES